688289 聖湘生物
按盤價 
21.500 +2.810 (+15.035%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.156 | 4.948 | 27.929 | 40.357 | 98.685 |
| 總資產報酬率 ROA (%) | 1.834 | 4.127 | 23.817 | 35.755 | 85.835 |
| 投入資產回報率 ROIC (%) | 2.056 | 4.845 | 27.468 | 39.555 | 96.520 | 邊際利潤分析 |
| 銷售毛利率 (%) | 77.266 | 71.539 | 58.834 | 71.668 | 79.636 |
| 營業利潤率 (%) | 24.327 | 42.444 | 36.274 | 58.074 | 64.792 |
| 息稅前利潤/營業總收入 (%) | 17.777 | 35.450 | 35.123 | 58.206 | 65.046 |
| 淨利潤/營業總收入 (%) | 18.920 | 34.571 | 30.025 | 49.673 | 54.936 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 77.247 | 6.158 | 109.765 | 96.776 | 99.853 |
| 價值變動淨收益/利潤總額(%) | -16.936 | 76.881 | 3.422 | 3.097 | 0.735 |
| 營業外收支淨額/利潤總額(%) | -3.633 | -4.138 | -1.031 | -0.213 | -0.517 | 償債能力分析 |
| 流動比率 (X) | 8.798 | 6.473 | 4.788 | 8.986 | 7.380 |
| 速動比率 (X) | 8.214 | 6.063 | 4.562 | 8.430 | 6.978 |
| 資產負債率 (%) | 13.529 | 12.175 | 18.106 | 10.000 | 12.998 |
| 帶息債務/全部投入資本 (%) | 5.333 | 1.050 | 0.483 | 0.949 | 2.025 |
| 股東權益/帶息債務 (%) | 1,750.824 | 9,285.780 | 20,361.485 | 10,364.053 | 4,816.617 |
| 股東權益/負債合計 (%) | 628.331 | 699.630 | 451.575 | 898.257 | 669.360 |
| 利息保障倍數 (X) | -3.120 | -6.679 | -44.984 | 227.525 | 110.757 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 170.277 | 351.351 | 57.791 | 52.447 | 26.792 |
| 存貨周轉天數 (天) | 424.392 | 459.635 | 49.133 | 90.945 | 63.355 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
